F16.21

Applicable To

• Other hallucinogen use disorder, moderate, in early remission

• Other hallucinogen use disorder, moderate, in sustained remission

• Other hallucinogen use disorder, severe, in early remission

• Other hallucinogen use disorder, severe, in sustained remission

• Phencyclidine use disorder, moderate, in early remission

• Phencyclidine use disorder, moderate, in sustained remission

• Phencyclidine use disorder, severe, in early remission

• Phencyclidine use disorder, severe, in sustained remission

Approximate Synonyms

• Hallucinogen dependence moderate use disorder), in early remission

• Hallucinogen dependence moderate use disorder), in sustained remission

• Hallucinogen dependence severe use disorder), in early remission

• Hallucinogen dependence severe use disorder), in sustained remission

• Hallucinogen dependence in remission

• Hallucinogen dependence, moderate use, in early remission

• Hallucinogen dependence, moderate use, in sustained remission

• Hallucinogen dependence, severe use, in early remission

• Hallucinogen dependence, severe use, in sustained remission

• Pcp dependence, in remission

• Phencyclidine dependence in remission

Details

• F16.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM F16.21 became effective on October 1, 2022.

• This is the American ICD-10-CM version of F16.21 – other international versions of ICD-10 F16.21 may differ.